How One Rheumatology Practice Bolstered Uptake Of Biosimilar Infliximab

Originally published in Biosimilar Development by Anna Rose Welch, Editor It never ceases to excite me when I hear that some organization, hospital, or clinic has found a way to bring biosimilars to its patients — regardless of all the noise happening in the industry today. Though I imagine there are more patients being treated …

How One Rheumatology Practice Bolstered Uptake Of Biosimilar Infliximab Read More »